FR2823976A1 - Nouvelle composition hormonale et son utilisation - Google Patents

Nouvelle composition hormonale et son utilisation Download PDF

Info

Publication number
FR2823976A1
FR2823976A1 FR0105557A FR0105557A FR2823976A1 FR 2823976 A1 FR2823976 A1 FR 2823976A1 FR 0105557 A FR0105557 A FR 0105557A FR 0105557 A FR0105557 A FR 0105557A FR 2823976 A1 FR2823976 A1 FR 2823976A1
Authority
FR
France
Prior art keywords
estroprogestative
estradiol
dose
compositions according
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR0105557A
Other languages
English (en)
French (fr)
Inventor
Jacques Paris
Jean Louis Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Priority to FR0105557A priority Critical patent/FR2823976A1/fr
Priority to MA26603A priority patent/MA26833A1/fr
Priority to AU2002310721A priority patent/AU2002310721A1/en
Priority to PCT/FR2002/001384 priority patent/WO2002085375A1/fr
Priority to KR1020027017624A priority patent/KR20030043797A/ko
Priority to BR0205104-4A priority patent/BR0205104A/pt
Priority to CN02802212A priority patent/CN1464787A/zh
Priority to ARP020101475A priority patent/AR033260A1/es
Publication of FR2823976A1 publication Critical patent/FR2823976A1/fr
Priority to NO20026215A priority patent/NO20026215L/no
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0105557A 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation Withdrawn FR2823976A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0105557A FR2823976A1 (fr) 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation
MA26603A MA26833A1 (fr) 2001-04-25 2002-04-15 Nouvelle composition hormonale et son utilisation
AU2002310721A AU2002310721A1 (en) 2001-04-25 2002-04-23 Novel hormone composition
PCT/FR2002/001384 WO2002085375A1 (fr) 2001-04-25 2002-04-23 Nouvelle composition hormonale et son utilisation
KR1020027017624A KR20030043797A (ko) 2001-04-25 2002-04-23 호르몬 조성물
BR0205104-4A BR0205104A (pt) 2001-04-25 2002-04-23 Composição hormonal inédita e sua utilização
CN02802212A CN1464787A (zh) 2001-04-25 2002-04-23 新的激素组合物
ARP020101475A AR033260A1 (es) 2001-04-25 2002-04-24 Nueva composicion hormonal y su utilizacion
NO20026215A NO20026215L (no) 2001-04-25 2002-12-23 Nytt hormonpreparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105557A FR2823976A1 (fr) 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation

Publications (1)

Publication Number Publication Date
FR2823976A1 true FR2823976A1 (fr) 2002-10-31

Family

ID=8862668

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0105557A Withdrawn FR2823976A1 (fr) 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation

Country Status (9)

Country Link
KR (1) KR20030043797A (pt)
CN (1) CN1464787A (pt)
AR (1) AR033260A1 (pt)
AU (1) AU2002310721A1 (pt)
BR (1) BR0205104A (pt)
FR (1) FR2823976A1 (pt)
MA (1) MA26833A1 (pt)
NO (1) NO20026215L (pt)
WO (1) WO2002085375A1 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006048261A2 (en) * 2004-11-02 2006-05-11 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US8022053B2 (en) 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136011A2 (en) * 1983-08-05 1985-04-03 Pre Jay Holdings Ltd. A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
FR2754179A1 (fr) * 1996-10-08 1998-04-10 Theramex Nouvelle composition hormononale et son utilisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136011A2 (en) * 1983-08-05 1985-04-03 Pre Jay Holdings Ltd. A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
FR2754179A1 (fr) * 1996-10-08 1998-04-10 Theramex Nouvelle composition hormononale et son utilisation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006048261A2 (en) * 2004-11-02 2006-05-11 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
WO2006048261A3 (en) * 2004-11-02 2006-09-21 Schering Ag Oral solid dosage forms containing a low dose of estradiol
EA013262B1 (ru) * 2004-11-02 2010-04-30 Байер Шеринг Фарма Акциенгезельшафт Пероральные твёрдые лекарственные формы, содержащие низкую дозу эстрадиола
US8022053B2 (en) 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol

Also Published As

Publication number Publication date
WO2002085375A1 (fr) 2002-10-31
NO20026215D0 (no) 2002-12-23
NO20026215L (no) 2003-02-21
KR20030043797A (ko) 2003-06-02
AU2002310721A1 (en) 2002-11-05
MA26833A1 (fr) 2004-12-20
BR0205104A (pt) 2003-05-20
WO2002085375A8 (fr) 2003-02-20
AR033260A1 (es) 2003-12-10
CN1464787A (zh) 2003-12-31

Similar Documents

Publication Publication Date Title
US9084796B2 (en) Hormonal composition and its use
JP2009143959A (ja) 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤
CA2268358C (fr) Composition hormonale constituee d'un compose estrogene et d'un compose progestatif
OA10411A (fr) Nouveaux médicaments hormonaux et leur utilisation pour la correction des carences estrogéniques
CA2388857C (fr) Medicament contraceptif a base d'un progestatif et d'un oestrogene et son mode de preparation
FR2823976A1 (fr) Nouvelle composition hormonale et son utilisation
WO2011069871A1 (en) A method for providing emergency contraception using ulipristal acetate
WO2000059447A2 (fr) Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables

Legal Events

Date Code Title Description
ST Notification of lapse